Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
Comprehensive clinical development programs being initiated for each investigational candidate
The company has received five final approvals
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
KBR will provide outreach, education and data analytics to support critical neuroscience research for the prevention and treatment of military members with CTE
First published clinical trial using live biotherapeutic candidate in Covid-19 patients suggests role in improving outcomes
Late-stage Fabhalta development program ongoing in multiple complement-mediated conditions
Ivabradine Tablets, 5 mg and 7.5 mg had annual sales of USD 136.5 mn in the United States
The receipt of this permission paves way for the launch of BREZTRI AEROSPHERE in India
Almost 300 million people globally have chronic hepatitis B
Subscribe To Our Newsletter & Stay Updated
